Benitec Biopharma Inc. Quarterly Current Ratio in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Benitec Biopharma Inc. quarterly Current Ratio history and growth rate from Q1 2021 to Q3 2024.
  • Benitec Biopharma Inc. Current Ratio for the quarter ending September 30, 2024 was 832 %, a 143% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 832 +489 +143% Sep 30, 2024
Q2 2024 608 +297 +95.9% Jun 30, 2024
Q1 2024 369 +9 +2.5% Mar 31, 2024
Q4 2023 335 -84.6 -20.2% Dec 31, 2023
Q3 2023 343 -94.4 -21.6% Sep 30, 2023
Q2 2023 310 -191 -38.1% Jun 30, 2023
Q1 2023 360 -435 -54.7% Mar 31, 2023
Q4 2022 420 -367 -46.6% Dec 31, 2022
Q3 2022 437 -593 -57.6% Sep 30, 2022
Q2 2022 501 -487 -49.3% Jun 30, 2022
Q1 2022 795 -54.1 -6.37% Mar 31, 2022
Q4 2021 786 Dec 31, 2021
Q3 2021 1.03K Sep 30, 2021
Q2 2021 988 Jun 30, 2021
Q1 2021 849 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.